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Introduction
Horticultural land within the periurban fringe of NZ towns 
and cities increasingly is being developed for residential 
subdivision. Recent surveys have shown that concentra-
tions of As, Cd, Cu, Pb, and ΣDDT (sum of DDT and its 
degradation products DDE and DDD) in such soils can 
exceed criteria protective of human health.1 Soil ingestion 
is a key exposure pathway for  non-volatile contaminants 
in soil. Currently in NZ, site-specific risk assessments 
and the derivation of soil guidelines protective of human 
health assume that all of the contaminant present in the 
soil is available for uptake and absorption by the human 
gastrointestinal tract. This assumption can overestimate 
health risks and has implications for the remediation of 
contaminated sites.2 In comparison, the bioavailability of 
contaminants is considered when estimating exposure via 
dermal absorption and by ingestion of home-grown pro-
duce.3 Dermal absorption factors and plant uptake factors 
are included in the calculations for estimating exposures 
via these routes.
Provided there are tools available to produce robust data 
on the bioavailability of contaminants in soil, it may be 
possible to derive site-specific guidelines that incorporate 
scientifically validated and refined risk scenarios. Site-
specific guidelines could reduce the scope and costs of 
remediation on former horticultural land. A range of in 
vivo and in vitro methods have been developed to assess 
bioavailability of contaminants in soil and these are gain-
ing increasing regulatory acceptance overseas.4 Little is 
known about the oral bioavailability of contaminants from 
NZ soils, and differences in soil properties may mean that 
overseas data may not be directly applicable to NZ con-
ditions. Herein, we provide an overview of methods to 
assess bioavailability of contaminants in soil via the oral 
route, and outline current barriers to using bioavailability 
in risk assessments for human exposure in NZ. In addi-
tion, the results of a preliminary investigation using the 
Solubility/Bioavailability Research Consortium (SBRC) 
Stomach-Phase Extraction in vitro method to estimate5 
the bioaccessible fraction of arsenic, cadmium, and lead 
in orchard soils are presented.
For human health risk assessments and the derivation 
of generic and site-specific soil guidelines, daily intakes 
from the relevant exposure pathways are estimated and 
compared with toxicological intakes. Intakes of carcino-
genic substances are assessed against index doses derived 
from dose-response relationships, and intakes of thresh-
old contaminants (non carcinogens and non-genotoxic 
carcinogens) are assessed against tolerable weekly (or 
daily) intakes.6 Such toxicological intakes can be derived 
either from animal dosing trials with appropriate safety 
factors, or from epidemiological data from populations 
exposed to the contaminant of interest.7 Toxicity param-
eters including tolerable daily intakes and index doses are 
generally calculated based on the intake dose.5,6
Definitions
The following definitions, adapted from Paustenbach,8 
are used herein:
Oral Bioaccessibility of a substance is the fraction of 
that substance that is soluble in the gastrointestinal en-
vironment and is available for absorption through the 
gastrointestinal tract and into the bloodstream.
Oral Bioavailability of a substance is defined as the 
fraction of an administered dose that reaches the 
bloodstream by absorption through the gastrointestinal 
tract.
Relative Bioavailability - The relative bioavailability 
of a substance refers to comparative bioavailabilities 
of different forms of that substance or for different ex-
posure media containing the substance.
Currently, the approach adopted in risk assessments for 
contaminated soil is to assume that the bioavailability of 
the contaminant in soil is equivalent to the bioavailabil-
ity of the contaminant in the matrix used to derive the 
toxicity parameter.9 Generally, in the studies used to de-
rive toxicological intakes, the contaminant of interest was 
ingested with water or food rather than soil.10 Often, in 
animal trials, trace elements have been reported as less 
bioavailable from soil than from other matrices such as 
food and drinking water8,11-13 because contaminants can 
remain adsorbed to soil in the human gastrointestinal 
tract.10 Factors that can reduce the oral bioavailability of 
contaminants in soil include the physicochemical proper-
ties, aging, chemical speciation, soil properties, particle 
size, and soil mineralogy.5,14
The following criteria have been proposed to identify 
when a site-specific bioavailability assessment can be un-
dertaken:5,11,15
• Concentrations of contaminants only slightly exceed 
soil quality criteria.
Feature
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• A limited number of contaminants exceed soil quality 
criteria.
• Soil ingestion is a key exposure pathway.
• The form of the contaminant is likely to have low rela-
tive bioavailability.
• The key contaminants are well aged in the soil.
• Remediation is costly or suitable techniques are un-
available.
• A large amount of land is involved.
• There is a risk of environmental degradation during soil 
remediation.
In vivo methods
In the absence of human studies or the availability of suit-
able epidemiological data, in vivo animal trials,16 using 
rabbits, rats, primates and pigs,5,17 have been used to mea-
sure the bioavailability of contaminants. Juvenile swine 
are commonly used to estimate the oral bioavailability of 
contaminants in soil for children, and to validate in vitro 
methods,5,10,13 because they are comparable in size and 
have similar gastrointestinal physiology.2,5 Testing proto-
cols vary depending upon the contaminant of interest and 
the animal species involved.5
In animal studies, one group of animals in the trial is fed 
contaminated soil and the other given the contaminant of 
interest in a (usually more soluble) form that is comparable 
to the one used in studies to derive toxicity values. Con-
centrations of the contaminant of interest present in body 
tissues and/or excreta are measured at intervals after dos-
ing, and the data are used to calculate a relative bioavail-
ability factor.5 However, animal trials are time consum-
ing, expensive, and raise ethical concerns.18 Additionally, 
concerns regarding the appropriateness of animal models 
as a surrogate measure for bioavailability in humans stem 
from differences in physiology and behaviour.17
In vitro methods
In vitro tests for measuring the bioavailability of contami-
nants have been developed to overcome the critical issues 
associated with animal testing.4,18 One further advantage 
of in vitro testing is that the tests can be designed to simu-
late the processes and conditions occurring in the human 
gastrointestinal tract.18 In vitro methods measure the bio-
accessible fraction of contaminants in soil, i.e. that pro-
portion of the contaminant that is desorbed from the soil 
in the human gastrointestinal tract and is potentially avail-
able for absorption. In vitro methods are suitable only for 
estimating the bioavailability of contaminants in soil if 
dissolution of the contaminant of interest is the rate-limit-
ing step for absorption.4
In vitro methods are generally based on the paediatric 
gastrointestinal tract.5 Soil is extracted at body tempera-
ture (37°C) with a simulated gastric fluid prepared from 
HCl and containing selected enzymes and amino acids. 
Summaries of the various simulated gastric extraction 
techniques are presented by Wragg and Cave,19 Oomen 
et al.,20 and Grøn and Anderson.11 Points of difference be-
tween simulated gastric extraction methods include solid 
to solution ratios, the inclusion of food to simulate fed or 
fasting conditions (dough or dairy products), and the in-
clusion of a second extraction stage to simulate processes 
occurring in the intestines.
The bioaccessibility factors determined for some trace 
elements correlate with relative bioavailability factors 
obtained from animal feeding trials.2,5 It should be noted 
that the correlation between the results from the in vitro 
and the in vivo methods may not be a one-to-one relation-
ship.8 However, not all in vitro methods have been vali-
dated against animal trials18 and the bioaccessible fraction 
does not always correlate with the relative bioavailability 
measured in an in vivo trial.17 While in vitro methods have 
been developed also for organic contaminants including 
polycyclic aromatic hydrocarbons (PAHs) and polychlo-
rinated biphenyls (PCBs), validation data for these con-
taminants have not been published.16 In vitro methods for 
organic contaminants will prove more difficult to validate 
using animal trials as the organic compounds also can be 
metabolised and/or degraded by microorganisms in the 
intestine.21
To date, in vitro methods have not been used routinely 
to estimate the bioaccessibility of trace elements in NZ 
soils, nor have they been validated against animal tri-
als. However, under the Toxic Substances Amendment 
Regulations (1999), a comparable simulated gastric acid 
extraction method is used to screen children’s graphic ma-
terials, i.e. paints and crayons, for toxic levels of selected 
trace elements.
Examples where in vitro testing methods have been used 
overseas include assessment of the bioaccessibility of 
naturally high concentrations of trace elements in soil, 
measurement of the bioaccessibility of arsenic in soil, 
derivation of site-specific soil criteria for arsenic, and in 
monitoring the effectiveness of in situ stabilization tech-
niques.22 In vitro testing methods also have been used to 
measure the bioaccessibility of contaminants in matrices 
other than soil including dust, children’s toys, and food.23
Case Study: Bioaccessibility of Arsenic, 
Cadmium and Lead in New Zealand 
orchard soils
Lead arsenate (PbHAsO
4
) was widely used as a pesticide 
in NZ orchards until the 1960s and Cd is a contaminant 
in fertilisers.24 Several investigations have shown that NZ 
orchard soils can contain As, Cd and Pb in concentra-
tions that exceed the levels protective of human health 
(Table 1).1,25 These elevated concentrations are of con-
cern when former orchards are converted into residential 
subdivisions. Contaminated orchard soils meet the crite-
ria detailed above for bioavailability assessments due to 
the large amount of land potentially involved, the limited 
remediation options for these elements in soils, and the 
potential for the remediation activities to have an adverse 
effect on the environment.
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Table 1. Range of selected trace element concentrations (mg/kg) 
from NZ orchard soils.
Region As Cd Pb Ref.
Auckland 2-34 0.1-1.1 11-178 1
Tasman 3-48 0.3-1.0 15-243 1
Waikato 4-58 0.8-1.5 14-251 1
Hawkes Bay 4-43 0.05-0.5 16-341 25
Methodology 
A modified version of the SBRC’s Standard Operat-
ing Procedure for Stomach-Phase Extraction5 was used 
to determine the bioaccessibility of As, Cd and Pb from 
ten orchard soils. For gastric extractions, the soils were 
sieved to <250 μm to represent the fraction of soil likely 
to adhere to children’s hands and be ingested.5 Briefly, for 
the gastric extraction, 1 g of <250 μm soil was extracted 
using 100 mL of simulated gastric fluid composed of 0.4 
M glycine adjusted to pH 1.5 with c.HCl. The resulting 
slurries were shaken on an orbital mixing incubator for 
1 h at 37ºC, filtered, and analysed for trace elements by 
ICP-MS.
Results
The percentage of bioaccessible fractions for As, Cd and 
Pb ranged from 12–45%, 64–100% and 56–83%, respec-
tively. The mean percentage bioaccessible fraction fol-
lowed the order: Cd > Pb > As and was consistent with 
order of extraction of metals from soils using the com-
parable Simple Bioaccessibility Extraction Test method 
developed by the UK Geological Survey.20 The range of 
%bioaccessible fraction for metals obtained indicates that 
the bioaccessibility of these contaminants in orchard soils 
varies on a site-specific basis. For As and Pb there was a 
significant correlation (Fig. 1) between the [Fe] and the 
%bioaccessible fraction, indicating that soil character-
istics are a controlling factor for the bioaccessibility of 
As and Pb. This also suggests that significant portions of 
these contaminants are present in a chemically speciated 
form associated with the iron content of the soil - specifi-
cally the amorphous iron-hydroxide phase.
Fig. 1. Relationships between the bioaccessible fraction (%) of 
As and Pb and the [Fe] (mg/kg) of the <250 μm soil fraction.
Barriers to Using Bioaccessibility Data in 
Risk Assessments
While the preliminary results presented in Fig. 1 indicate 
that bioaccessibility of trace elements is likely to vary be-
tween orchard sites, there are several barriers to introduc-
ing in vitro testing as part of risk assessments in NZ in the 
short term.2,10,19,26 These barriers include:
1. Lack of international consensus on the appropriate test 
method(s) to determine bioaccessibility due to:
• variability of results between test methods, soil types, 
and test laboratories;
• concerns of the relevance of in vitro tests to human 
exposures to contaminants in soil, and the scientific 
validity of the tests;
• limited method validation including human data and 
few reference materials to support inter-laboratory 
validation of methods.
2. Lack of policy to support the use of bioaccessibility ad-
justments including:
• guidance on how to incorporate bioaccessibility/bio-
availability adjustments into risk assessment.
3. Lack of information on the bioaccessibility of contami-
nants in food. 
4. Questions regarding the appropriateness of adjusting 
the currently available toxicological intakes.
5. Limited information on the long-term stability of bioac-
cessibility measurements.
6. Lack of awareness of some end users of the limitations 
of in vitro test methods.
7. Regulatory acceptance.
It is possible that bioaccessibility could be incorporated 
into risk assessments in the future provided that the issues 
identified above can be resolved, and international con-
sensus reached. Bioaccessibility of contaminants in soil is 
an active area of research. There are several international 
collaborations underway aimed to improve understanding 
of the scientific validity of in vitro bioaccessibility test-
ing, and to identify standard test methods. These include 
Bioavailability Research Canada (BARC), the Bioavail-
ability Research Group Europe (BARGE), and the Solu-
bility/Bioavailability Research Consortium (US). In addi-
tion, the International Standards Organisation (ISO) has 
recently published a standard for bioaccessibility - Soil 
Quality: Assessment of human exposure from ingestion of 
soil and soil material; guidance on the application and 
selection of physiologically-based extraction methods for 
the estimation of the human bioaccessibility/bioavailabil-
ity of metals in soil (ISO/TS 17294:2007).
The validity and acceptability of bioaccessibility testing 
in NZ has yet to be subjected to governmental evaluation. 
Moreover, NZ has not participated in the international 
collaborative projects for validating and standardizing in 
vitro test methods for contaminants in soil. The Ministry 
for the Environment is currently developing a nationally 
consistent NZ risk-based methodology for deriving soil 
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contaminants for human health.27 The question of wheth-
er or not bioaccessibility-based adjustments are able to be 
readily accommodated within this methodology will need 
to be considered by the Ministry’s Technical Reference 
Group as part of this work.
Summary
Internationally, in vitro methods are being used to esti-
mate the bioaccessible fraction of contaminants in soil. 
These chemical extraction methods simulate conditions 
and processes occurring in the human gastrointestinal 
tract and provide a surrogate measure of bioavailability. 
An in vitro method was used to estimate the bioaccessible 
fraction of arsenic, cadmium, and lead in orchard soils 
and gave values that ranged from 12–45% for As, 64–
100% for Cd, and 56–83% for Pb. These results indicate 
that the oral bioaccessibility of these metals can vary on a 
site-specific basis and that it may be feasible, under some 
circumstances, to derive site-specific guidelines to protect 
human health. However, there are significant barriers to 
using bioaccessibility data in risk assessments, including 
questions regarding the relevance of the in vitro testing, 
and a lack of guidance on how to incorporate bioacces-
sibility values into risk assessments.
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